Browse our 650+ Publications​

Latest Publications

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

Formenti et al.
Nature Medicine
December 2018
Authors and Affiliates
Formenti SC1, Rudqvist NP2, Golden E2,3, Cooper B4, Wennerberg E2, Lhuillier C2, Vanpouille-Box C2, Friedman K5, Ferrari de Andrade L6,7, Wucherpfennig KW6,7, Heguy A8,9, Imai N10, Gnjatic S10, Emerson RO11, Zhou XK12, Zhang T13, Chachoua A14, Demaria S15,16. 1 Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. formenti@med.cornell.edu. 2 Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. 3 Department of Radiation Oncology, University of California, San Francisco, CA, USA. 4 Department of Radiation Oncology, New York University School of Medicine, New York, NY, USA. 5 Department of Radiology, New York University School of Medicine, New York, NY, USA. 6 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. 7 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA. 8 Department of Pathology, New York University School of Medicine, New York, NY, USA. 9 Genome Technology Center, Division of Advanced research Technologies, NYU Langone Health, New York, NY, USA. 10 Tisch Cancer Institute, Hematology/Oncology, Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 11 Adaptive Biotechnologies, Seattle, WA, USA. 12 Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA. 13 Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA. 14 Department of Medicine, New York University School of Medicine, New York, NY, USA. 15 Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. szd3005@med.cornell.edu. 16 Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. szd3005@med.cornell.edu.

Human retinoic acid–regulated CD161+ regulatory T cells support wound repair in intestinal mucosa

Povoleri et al.
Nature Immunology
December 2018
Authors and Affiliates
Povoleri GAM1,2, Nova-Lamperti E1,2, Scottà C1,2, Fanelli G1,2, Chen YC3, Becker PD1,2, Boardman D1,2, Costantini B4, Romano M1,2, Pavlidis P1,2, McGregor R1,2, Pantazi E1,2, Chauss D5, Sun HW6, Shih HY7, Cousins DJ8, Cooper N9, Powell N1,2, Kemper C10, Pirooznia M3, Laurence A11, Kordasti S4, Kazemian M12, Lombardi G1,2, Afzali B13,14,15 1 MRC, Centre for Transplantation, King's College London, London, UK. 2 National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK. 3 Bioinformatics and Computational Biology Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. 4 Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. 5 Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA. 6 Biodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA. 7 Lymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA. 8 Department of Infection, Immunity and Inflammation, NIHR Leicester Respiratory Biomedical Research Unit, University of Leicester, Leicester, UK. 9 Department of Medicine, Imperial College London, London, UK. 10 Complement and Inflammation Research Section, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. 11 Institute of Cellular Medicine, Newcastle University, Newcastle, UK. 12 Departments of Biochemistry and Computer Science, Purdue University, West Lafayette, IN, USA. 13 MRC, Centre for Transplantation, King's College London, London, UK. behdad.afzali@nih.gov. 14 Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA. behdad.afzali@nih.gov. 15 National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. behdad.afzali@nih.gov.

Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells

Ruck et al.
Neurology
December 2018
Authors and Affiliates
Ruck T1, Pfeuffer S2, Schulte-Mecklenbeck A2, Gross CC2, Lindner M2, Metze D2, Ehrchen J2, Sondermann W2, Pul R2, Kleinschnitz C2, Wiendl H2, Meuth SG2, Klotz L2. 1 From the Clinic of Neurology with Institute of Translational Neurology (T.R., S.P., A.S.-M., C.C.G., M.L., H.W., S.G.M., L.K.) and Department of Dermatology (D.M., J.E.), University of Münster; and Departments of Dermatology, Venereology, and Allergology (W.S.) and Neurology (R.P., C.K.), University School of Medicine Essen-Duisburg, Essen, Germany. tobias.ruck@ukmuenster.de. 2 From the Clinic of Neurology with Institute of Translational Neurology (T.R., S.P., A.S.-M., C.C.G., M.L., H.W., S.G.M., L.K.) and Department of Dermatology (D.M., J.E.), University of Münster; and Departments of Dermatology, Venereology, and Allergology (W.S.) and Neurology (R.P., C.K.), University School of Medicine Essen-Duisburg, Essen, Germany.

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors

Chee et al.
BMC Research Notes
December 2018
Authors and Affiliates
Chee J1, Watson MW2, Chopra A2, Nguyen B3, Cook AM4, Creaney J4, Lesterhuis WJ4, Robinson BW4,5, Lee YCG5,6, Nowak AK4,3, Lake RA4, McDonnell AM4 1 National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia. jonathan.chee@uwa.edu.au. 2 Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia. 3 Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. 4 National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia. 5 Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. 6 Institute of Respiratory Health, School of Medicine, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

Erhart et al.
Acta Neuropathologica
December 2018
Authors and Affiliates
Erhart F1,2, Buchroithner J3, Reitermaier R4, Fischhuber K4, Klingenbrunner S4, Sloma I5, Hibsh D5, Kozol R5, Efroni S5, Ricken G6, Wöhrer A6, Haberler C6, Hainfellner J6, Krumpl G4, Felzmann T4, Dohnal AM7, Marosi C8, Visus C4 1-Institute of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1097, Vienna, Austria. friedrich.erhart@meduniwien.ac.at. 2-Department of Neurosurgery, Medical University of Vienna, Währinger Gürtel 18-20, 1097, Vienna, Austria. friedrich.erhart@meduniwien.ac.at. 3-University Clinic for Neurosurgery, Kepler University Hospital, Johannes Kepler University, Wagner-Jauregg-Weg 15, 4020, Linz, Austria. 4-Activartis Biotech GmbH, Wilhelminenstraße 91/IIf, 1160, Vienna, Austria. 5-Systems Bio Medicine Lab, Bar Ilan University, 5290002, Ramat Gan, Israel. 6-Institute of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1097, Vienna, Austria. 7-Laboratory for Tumor Immunology, CCRI St. Anna Kinderkrebsforschung, Zimmermannplatz 10, 1090, Vienna, Austria. 8-Clinical Division of Medical Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1097, Vienna, Austria.

Identifying and Tracking Low-Frequency Virus-Specific TCR Clonotypes Using High-Throughput Sequencing

Wolf et al.
Cancer Reports
November 2018
Authors and Affiliates
Wolf K1, Hether T2, Gilchuk P3, Kumar A3, Rajeh A4, Schiebout C4, Maybruck J5, Buller RM1, Ahn TH6, Joyce S3, DiPaolo RJ7. 1 Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO 63104, USA. 2 Adaptive Biotechnologies, Seattle, WA 98102, USA. 3 Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN 37212, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN 37232, USA. 4 Program in Bioinformatics and Computational Biology, Saint Louis University, Saint Louis, MO 63104, USA. 5 Federal Bureau of Investigation, Washington, DC 20535, USA. 6 Department of Computer Science, Saint Louis University, Saint Louis, MO 63104, USA; Program in Bioinformatics and Computational Biology, Saint Louis University, Saint Louis, MO 63104, USA. 7 Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO 63104, USA. Electronic address: richard.dipaolo@health.slu.edu.

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Blank et al.
Nature Medicine
November 2018
Authors and Affiliates
Blank CU1,2, Rozeman EA3,4, Fanchi LF4, Sikorska K5, van de Wiel B6, Kvistborg P4, Krijgsman O4, van den Braber M4, Philips D4, Broeks A6, van Thienen JV3, Mallo HA3, Adriaansz S3, Ter Meulen S7, Pronk LM5, Grijpink-Ongering LG5, Bruining A8, Gittelman RM9, Warren S10, van Tinteren H5, Peeper DS4, Haanen JBAG3,4, van Akkooi ACJ7, Schumacher TN11. 1 Medical Oncology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands. c.blank@nki.nl. 2 Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. c.blank@nki.nl. 3 Medical Oncology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands. 4 Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. 5 Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands. 6 Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. 7 Surgical Oncology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands. 8 Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. 9 Adaptive Biotechnologies, Seattle, WA, USA. 10 NanoString Technologies, Inc., Seattle, WA, USA. 11 Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. t.schumacher@nki.nl.

Microphysiologic Human Tissue Constructs Reproduce Autologous Age-Specific BCG and HBV Primary Immunization in vitro

Sanchez-Schmitz et al.
Frontiers in Immunology
November 2018
Authors and Affiliates
Sanchez-Schmitz G1,2,3, Stevens CR1, Bettencourt IA1, Flynn PJ1, Schmitz-Abe K2,3,4,5, Metser G1, Hamm D6, Jensen KJ7,8,9, Benn C7,8, Levy O1,2,3,5 1 Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States. 2 Precision Vaccines Program, Boston Children's Hospital, Boston, MA, United States. 3 Harvard Medical School, Harvard University, Boston, MA, United States. 4 Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States. 5 Broad Institute of Harvard and MIT, Cambridge, MA, United States. 6 Adaptive Biotechnologies, Seattle, WA, United States. 7 Research Center for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark. 8 Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau. 9 Department of Biotechnology and Biomedicine, Technical University of Denmark, Kgs Lyngby, Denmark.
Previous Next